110229 ⎘
Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use Thereof
#2COMBINATION THERAPY OF HBV AND HDV INFECTION
#3Compositions and methods for treating viral infections
#4THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS
#5Modified antimicrobial peptide derived from an arginine-rich domain
#6Hepatitis B virus-derived polypeptide and anti-viral use thereof
#7T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
#8Antibody based gene therapy with tissue-directed expression
#9Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain
#10Cyclic NTCP-targeting peptides and their uses as entry inhibitors
#11Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors
#12Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#13Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
#14Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#15INDUCTION OF IMMUNE RESPONSE
#16Antimicrobial peptides derived from hepatitis B virus core protein arginine-rich domain
#17Modified viral structural protein with antiviral activity
#18HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF
#19HEPATITIS B VIRUS PRE-S1 DERIVED SYNTHETIC POLYPEPTIDES AND USES THEREOF
#20Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof
#21Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof